V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001650 | 330000937 | 1.81 | 33 | Palliative (P) | 2015-08-28 | 2015-09-01 | Trial Unspecified | Y | N | 330005570 | TRIAL |
| 330001651 | 330006524 | 1.72 | null | Curative (C) | null | 2014-07-03 | Cisplatin 7 day | N | Y | 330005578 | CISPLATIN |
| 330001652 | 330000938 | null | 99.5 | Neo-adjuvant (N) | 2017-02-23 | 2017-02-26 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330005579 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001653 | 330000939 | 1.9 | 86 | Curative (C) | 2016-11-03 | 2016-11-29 | Cisplatin | 02 | Y | 330005583 | CISPLATIN |
| 330001654 | 330000939 | 1.83 | 99.8 | Neo-adjuvant (N) | 2015-03-23 | 2015-04-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330005583 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001655 | 330000939 | null | 58 | Neo-adjuvant (N) | null | 2015-07-28 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330005583 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001656 | 330000940 | 1.6 | null | Curative (C) | 2015-01-15 | 2015-01-15 | Cisplatin | N | Y | 330005595 | CISPLATIN |
| 330001657 | 330000941 | null | null | Curative (C) | 2013-07-06 | 2013-10-31 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330005596 | NOT MATCHED |
| 330001658 | 330000941 | 1.64 | 53.2 | Curative (C) | null | 2014-07-10 | Cisplatin 7 day | N | N | 330005596 | CISPLATIN |
| 330001659 | 330000942 | null | 49.9 | Curative (C) | 2017-06-04 | 2017-06-04 | EW EuroEwing 2012 Arm A VAC | null | Y | 330005613 | NOT MATCHED |
| 330001660 | 330000943 | null | 13 | Curative (C) | 2016-12-29 | 2017-01-11 | Trial Unspecified | N | N | 330005616 | TRIAL |
| 330001661 | 330000944 | 1.68 | 11.5 | Curative (C) | 2014-05-01 | 2014-05-02 | Trial Unspecified | Y | N | 330005621 | TRIAL |
| 330001662 | 330000945 | null | 78.5 | Curative (C) | 2016-09-26 | 2016-09-26 | WT SIOP 2002 01 post op Carbo, Etop | null | N | 330005625 | NOT MATCHED |
| 330001663 | 330000946 | null | 38.7 | Curative (C) | 2017-10-28 | 2017-11-17 | CNS GCT II | N | N | 330005626 | NOT MATCHED |
| 330001664 | 330000947 | 1.82 | 82 | Adjuvant (A) | null | 2015-10-02 | Cisplatin 7 day | N | N | 330005629 | CISPLATIN |
| 330001665 | 330000948 | 1.52 | 11.5 | Curative (C) | 2018-10-11 | 2018-10-15 | EW EuroEwing 2012 Arm B VDC | Y | null | 330005632 | TRIAL |
| 330001666 | 330000948 | null | 70.6 | Curative (C) | 2016-12-16 | 2016-12-18 | Cisplatin | N | N | 330005632 | CISPLATIN |
| 330001667 | 330000949 | 1.6 | 4.2 | null | 2017-08-31 | 2017-09-03 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005637 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001668 | 330006528 | null | null | Curative (C) | 2015-01-22 | 2015-02-03 | Cisplatin | 02 | Y | 330005641 | CISPLATIN |
| 330001669 | 330000950 | null | 67.7 | Curative (C) | 2015-11-21 | 2015-11-30 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330005649 | NOT MATCHED |
| 330001670 | 330000950 | 0 | 56.4 | Palliative (P) | 2018-01-29 | 2018-01-30 | Trial Unspecified | Y | N | 330005649 | TRIAL |
| 330001671 | 330000950 | 1.71 | 12.6 | null | 2013-12-06 | 2013-12-19 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005649 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001672 | 330000950 | 1.32 | 52 | Neo-adjuvant (N) | null | 2017-04-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330005649 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001673 | 330000950 | 1.48 | null | Disease modification (D) | 2015-08-25 | 2015-09-01 | EW EuroEwing 2012 Arm B VDC | null | null | 330005649 | TRIAL |
| 330001674 | 330000951 | 1.72 | 65 | Adjuvant (A) | 2017-07-30 | 2017-08-04 | Cisplatin 7 day | 02 | Y | 330005667 | CISPLATIN |
| 330001675 | 330000951 | 1.75 | 64 | Not known (9) | 2015-04-11 | 2015-05-16 | Cisplatin 7 day | N | Y | 330005667 | CISPLATIN |
| 330001676 | 330000952 | 1.81 | 57.1 | Curative (C) | 2016-06-19 | 2016-06-19 | Trial Unspecified | 01 | Y | 330005676 | TRIAL |
| 330001677 | 330006531 | 1.72 | 25.5 | Curative (C) | 2017-10-07 | 2017-10-28 | Trial Unspecified | Y | N | 330005677 | TRIAL |
| 330001678 | 330000953 | 1.73 | 16.1 | Curative (C) | null | 2017-01-12 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330005679 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001679 | 330000954 | 0 | 26.6 | Curative (C) | 2017-08-09 | 2017-08-09 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330005682 | NOT MATCHED |
| 330001680 | 330000954 | 1.68 | 83 | Curative (C) | null | 2018-04-07 | Cisplatin | 02 | Y | 330005682 | CISPLATIN |
| 330001681 | 330000954 | 1.1 | 20.7 | Curative (C) | 2018-01-24 | 2018-02-02 | EW EuroEwing 2012 Arm B IE | N | N | 330005682 | TRIAL |
| 330001682 | 330000955 | 1.6 | 8.9 | Curative (C) | 2017-01-03 | 2017-01-29 | Cisplatin 7 day | N | N | 330005689 | CISPLATIN |
| 330001683 | 330000956 | 1.57 | 60.4 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330005691 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001684 | 330000956 | 1.8 | 19.8 | Adjuvant (A) | 2016-02-25 | 2016-03-27 | Cisplatin | N | N | 330005691 | CISPLATIN |
| 330001685 | 330000957 | null | 67 | Disease modification (D) | 2015-11-25 | 2015-11-27 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | Y | null | 330005698 | NOT MATCHED |
| 330001686 | 330000958 | 1.59 | 53 | Palliative (P) | 2013-02-17 | 2013-03-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005699 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001687 | 330000959 | 1.79 | 58.4 | Curative (C) | 2013-05-10 | 2013-05-16 | Trial Unspecified | 1 | N | 330005701 | TRIAL |
| 330001688 | 330000960 | 1.59 | 0 | Neo-adjuvant (N) | 2016-12-23 | 2016-12-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330005702 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001689 | 330000961 | 1.8 | 90 | Neo-adjuvant (N) | 2016-11-12 | 2016-11-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005706 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001690 | 330000962 | 0 | 58.5 | Curative (C) | 2015-07-26 | 2015-07-26 | null | N | N | 330005711 | NOT MATCHED |
| 330001691 | 330000963 | 1.53 | 56.8 | Curative (C) | 2015-07-05 | 2015-08-09 | Cisplatin | 02 | Y | 330005712 | CISPLATIN |
| 330001692 | 330000963 | 1.89 | 20.5 | Palliative (P) | null | 2017-02-09 | Trial Unspecified | Y | N | 330005712 | TRIAL |
| 330001693 | 330000963 | 0.89 | null | Disease modification (D) | 2016-06-04 | 2016-06-04 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330005712 | NOT MATCHED |
| 330001694 | 330000964 | 1.7 | 71.3 | Curative (C) | null | 2015-12-01 | Cisplatin 7 day | N | N | 330005720 | CISPLATIN |
| 330001695 | 330000965 | 0 | 72 | Curative (C) | null | 2014-04-06 | OST Euramos 1 Closed Trial - Ai | 2 | N | 330005721 | NOT MATCHED |
| 330001696 | 330000966 | 1.74 | 13.4 | Curative (C) | 2016-08-22 | 2016-09-19 | Cisplatin 7 day | N | N | 330005724 | CISPLATIN |
| 330001697 | 330000967 | 1.69 | 34 | null | 2017-05-10 | 2017-05-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 330005732 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001698 | 330000968 | null | 64.2 | Curative (C) | 2017-01-20 | 2017-01-24 | LCHIV IC-2 | Y | N | 330005735 | NOT MATCHED |
| 330001699 | 330000968 | 1.8 | 72.1 | Neo-adjuvant (N) | 2016-01-21 | 2016-02-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330005735 | CISPLATIN + DOCETAXEL + FLUOROURACIL |